Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson’s disease. The papers, published in Nature this week, investigate the use of cells derived from human induced pluripotent stem cells and human embryonic stem cells, respectively. However, further research is needed to test the effectiveness and clinical benefits of these therapies.